138 related articles for article (PubMed ID: 32277344)
1. Comparable Effect of Two-Step Versus Extended Infusions on the Pharmacokinetics of Imipenem in Patients with Sepsis and Septic Shock.
Huang Y; Xu K; Zhan Y; Zha X; Liu S; Xie J; Liu L; Li Q; Shao H; Yang Y
Adv Ther; 2020 May; 37(5):2246-2255. PubMed ID: 32277344
[TBL] [Abstract][Full Text] [Related]
2. Association Between Pathophysiology and Volume of Distribution Among Patients With Sepsis or Septic Shock Treated With Imipenem: A Prospective Cohort Study.
Huang Y; Yang J; Xie J; Liu L; Liu S; Guo F; Qiu H; Yang Y
J Infect Dis; 2020 Mar; 221(Suppl 2):S272-S278. PubMed ID: 32176787
[TBL] [Abstract][Full Text] [Related]
3. Optimisation of imipenem regimens in patients with impaired renal function by pharmacokinetic-pharmacodynamic target attainment analysis of plasma and urinary concentration data.
Yoshizawa K; Ikawa K; Ikeda K; Kumon H; Ohge H; Morikawa N
Int J Antimicrob Agents; 2012 Nov; 40(5):427-33. PubMed ID: 22877766
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of imipenem in critically ill patients during empirical treatment of nosocomial pneumonia: a comparison of 0.5-h and 3-h infusions.
Lipš M; Siller M; Strojil J; Urbánek K; Balík M; Suchánková H
Int J Antimicrob Agents; 2014 Oct; 44(4):358-62. PubMed ID: 25216543
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamic modeling of beta-lactam antibiotics for the empiric treatment of secondary peritonitis: a report from the OPTAMA program.
Kotapati S; Kuti JL; Nicolau DP
Surg Infect (Larchmt); 2005; 6(3):297-304. PubMed ID: 16201939
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of imipenem in critically ill patients with suspected ventilator-associated pneumonia and evaluation of dosage regimens.
Couffignal C; Pajot O; Laouénan C; Burdet C; Foucrier A; Wolff M; Armand-Lefevre L; Mentré F; Massias L
Br J Clin Pharmacol; 2014 Nov; 78(5):1022-34. PubMed ID: 24903189
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of imipenem in healthy volunteers following administration by 2 h or 0.5 h infusion.
Jaruratanasirikul S; Raungsri N; Punyo J; Sriwiriyajan S
J Antimicrob Chemother; 2005 Dec; 56(6):1163-5. PubMed ID: 16234333
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics and pharmacodynamics of continuous versus short-term infusion of imipenem-cilastatin in critically ill patients in a randomized, controlled trial.
Sakka SG; Glauner AK; Bulitta JB; Kinzig-Schippers M; Pfister W; Drusano GL; Sörgel F
Antimicrob Agents Chemother; 2007 Sep; 51(9):3304-10. PubMed ID: 17620371
[TBL] [Abstract][Full Text] [Related]
9. Is continuous infusion of imipenem always the best choice?
Suchánková H; Lipš M; Urbánek K; Neely MN; Strojil J
Int J Antimicrob Agents; 2017 Mar; 49(3):348-354. PubMed ID: 28189734
[TBL] [Abstract][Full Text] [Related]
10. Probability of pharmacodynamic target attainment with standard and prolonged-infusion antibiotic regimens for empiric therapy in adults with hospital-acquired pneumonia.
Kim A; Kuti JL; Nicolau DP
Clin Ther; 2009 Nov; 31(11):2765-78. PubMed ID: 20110018
[TBL] [Abstract][Full Text] [Related]
11. Impact of cumulative fluid balance on the pharmacokinetics of extended infusion meropenem in critically ill patients with sepsis.
Pařízková RČ; Martínková J; Havel E; Šafránek P; Kaška M; Astapenko D; Bezouška J; Chládek J; Černý V
Crit Care; 2021 Jul; 25(1):251. PubMed ID: 34274013
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and Monte Carlo Dosing Simulations of Imipenem in Critically Ill Patients with Life-Threatening Severe Infections During Support with Extracorporeal Membrane Oxygenation.
Jaruratanasirikul S; Vattanavanit V; Wongpoowarak W; Nawakitrangsan M; Samaeng M
Eur J Drug Metab Pharmacokinet; 2020 Dec; 45(6):735-747. PubMed ID: 32886347
[TBL] [Abstract][Full Text] [Related]
13. Higher versus standard amikacin single dose in emergency department patients with severe sepsis and septic shock: a randomised controlled trial.
De Winter S; Wauters J; Meersseman W; Verhaegen J; Van Wijngaerden E; Peetermans W; Annaert P; Verelst S; Spriet I
Int J Antimicrob Agents; 2018 Apr; 51(4):562-570. PubMed ID: 29180278
[TBL] [Abstract][Full Text] [Related]
14. Optimized meropenem dosage regimens using a pharmacokinetic/pharmacodynamic population approach in patients undergoing continuous venovenous haemodiafiltration with high-adsorbent membrane.
Padullés Zamora A; Juvany Roig R; Leiva Badosa E; Sabater Riera J; Pérez Fernández XL; Cárdenas Campos P; Rigo Bonin R; Alía Ramos P; Tubau Quintano F; Sospedra Martinez E; Colom Codina H
J Antimicrob Chemother; 2019 Oct; 74(10):2979-2983. PubMed ID: 31335959
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic modeling of imipenem-cilastatin, meropenem, and piperacillin-tazobactam for empiric therapy of skin and soft tissue infections: a report from the OPTAMA Program.
Ong CT; Kuti JL; Nicolau DP;
Surg Infect (Larchmt); 2005; 6(4):419-26. PubMed ID: 16433606
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics and dosing simulations of imipenem in serious bacteraemia in immunocompromised patients with febrile neutropenia.
Jaruratanasirikul S; Wongpoowarak W; Jullangkoon M; Samaeng M
J Pharmacol Sci; 2015 Feb; 127(2):164-9. PubMed ID: 25727953
[TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacokinetics of 3-h extended infusion of meropenem in adult patients with severe sepsis and septic shock: implications for empirical therapy against Gram-negative bacteria.
Kothekar AT; Divatia JV; Myatra SN; Patil A; Nookala Krishnamurthy M; Maheshwarappa HM; Siddiqui SS; Gurjar M; Biswas S; Gota V
Ann Intensive Care; 2020 Jan; 10(1):4. PubMed ID: 31925610
[TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetic models of first choice beta-lactam antibiotics for severe infections treatment: What antibiotic regimen to prescribe in children?
Marsot A
J Pharm Pharm Sci; 2020; 23():470-485. PubMed ID: 33227230
[TBL] [Abstract][Full Text] [Related]
19. NONMEM population pharmacokinetics and Monte Carlo dosing simulations of imipenem in critically ill patients with life-threatening severe infections during support with or without extracorporeal membrane oxygenation in an intensive care unit.
Jaruratanasirikul S; Boonpeng A; Nawakitrangsan M; Samaeng M
Pharmacotherapy; 2021 Jul; 41(7):572-597. PubMed ID: 34080708
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of piperacillin in the early phase of septic shock: does standard dosing result in therapeutic plasma concentrations?
Öbrink-Hansen K; Juul RV; Storgaard M; Thomsen MK; Hardlei TF; Brock B; Kreilgaard M; Gjedsted J
Antimicrob Agents Chemother; 2015 Nov; 59(11):7018-26. PubMed ID: 26349823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
